201 related articles for article (PubMed ID: 11858798)
1. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
[TBL] [Abstract][Full Text] [Related]
2. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects.
Dalpiaz A; Ferretti ME; Pecoraro R; Fabbri E; Traniello S; Scatturin A; Spisani S
Biochim Biophys Acta; 1999 Jun; 1432(1):27-39. PubMed ID: 10366725
[TBL] [Abstract][Full Text] [Related]
3. Conformational aspects of human formylpeptide receptor antagonists.
Scatturin A; Vertuani G; Pecoraro R; Dalpiaz A; Boggian M; Ferretti ME; Spisani S
Arzneimittelforschung; 1999 Oct; 49(10):873-7. PubMed ID: 10554666
[TBL] [Abstract][Full Text] [Related]
4. Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors.
Dalpiaz A; Scatturin A; Vertuani G; Pecoraro R; Borea PA; Varani K; Traniello S; Spisani S
Eur J Pharmacol; 2001 Jan; 411(3):327-33. PubMed ID: 11164392
[TBL] [Abstract][Full Text] [Related]
5. Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.
Pagani Zecchini G; Nalli M; Mollica A; Lucente G; Paglialunga Paradisi M; Spisani S
J Pept Res; 2002 Jun; 59(6):283-91. PubMed ID: 12010519
[TBL] [Abstract][Full Text] [Related]
6. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.
Seifert R; Schultz G; Richter-Freund M; Metzger J; Wiesmüller KH; Jung G; Bessler WG; Hauschildt S
Biochem J; 1990 May; 267(3):795-802. PubMed ID: 2160237
[TBL] [Abstract][Full Text] [Related]
7. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat.
Bautista AP; Elliott KE
Life Sci; 1994; 54(11):721-30. PubMed ID: 8107522
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.
Mollica A; Feliciani F; Stefanucci A; Costante R; Lucente G; Pinnen F; Notaristefano D; Spisani S
J Pept Sci; 2012 Jun; 18(6):418-26. PubMed ID: 22528501
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
Derian CK; Solomon HF; Higgins JD; Beblavy MJ; Santulli RJ; Bridger GJ; Pike MC; Kroon DJ; Fischman AJ
Biochemistry; 1996 Jan; 35(4):1265-9. PubMed ID: 8573582
[TBL] [Abstract][Full Text] [Related]
10. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
Cavicchioni G; Breveglieri A; Boggian M; Vertuani G; Reali E; Spisani S
J Pept Sci; 1996; 2(3):135-40. PubMed ID: 9231322
[TBL] [Abstract][Full Text] [Related]
11. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
Bonora GM; Toniolo C; Freer RJ; Becker EL
Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
[TBL] [Abstract][Full Text] [Related]
12. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist.
Johansson B; Wymann MP; Holmgren-Peterson K; Magnusson KE
J Cell Biol; 1993 Jun; 121(6):1281-9. PubMed ID: 8509449
[TBL] [Abstract][Full Text] [Related]
13. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
14. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
Gnessi L; Ruff MR; Fraioli F; Pert CB
Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
[TBL] [Abstract][Full Text] [Related]
16. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
17. Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide.
Cavicchioni G; Turchetti M; Varani K; Falzarano S; Spisani S
Bioorg Chem; 2003 Aug; 31(4):322-30. PubMed ID: 12877881
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.
Ferretti ME; Nalli M; Biondi C; Colamussi ML; Pavan B; Traniello S; Spisani S
Cell Signal; 2001 Apr; 13(4):233-40. PubMed ID: 11306240
[TBL] [Abstract][Full Text] [Related]
19. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
